Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories

Company news

DEEPCHEK® ASSAY 13-PLEX KB DRUG SUSCEPTIBILITY TESTING IS NOW CE-IVD MARKED

We are pleased to announce that our DeepChek® Assay 13-Plex KB Drug Susceptibility Testing, intended to be used for Tuberculosis Drug Resistance assessment through NGS sequencing, is now CE-IVD marked !



See all